Abstract:Cancer cells are characterized by chromosomal re-arrangements which range from small deletions and insertions (InDels) to complete genome re-organization such as kataegis and chromothripsis. These genomic re-arrangements accompanied by other mutation signatures act as drivers of cellular transformation and immortalization. One form of re-arrangement is the intra-chromosomal deletion (ICD) which is larger than an InDel and can wipe out entire genomic sequences. Recurrent ICDs have been shown to inactivate key cell cycle regulators (e.g., Rb, PTEN, TP53) and contribute to cellular transformation. However, cancer cells are replete with ICDs of unknown function. ICDs arise due to failure of the DNA double strand break (DSB) repair machinery but the mechanism remains elusive. Mutations in three Mutations in key DNA damage repair genes such as the breast cancer susceptibility genes BRCA1 and BRCA2 as well as the accessory gene RAD52 accelerate ICD formation. Using the yeast model system, we identified physical and genetic interactions between RAD52 and two chromatin remodeling factors (KAT5 and HIRA). KAT5 is a histone acetyltransferase with functions in both transcription and DSB repair while HIRA is a histone chaperone required for re-deposition of nucleosomes following repair. We will present results from computational analysis of cancer genomes as well as experimental bench data that show that mutations in KAT5 and HIRA affect ICD formation. Epistatic analysis between the histone remodelers and BRCA1, BRCA2 and RAD52 reveals that co-occurring mutations contribute to destabilization of the repair machinery. In silico protein structure analysis was performed to model how mutations affect the function of these enzymes. Our data uncovers unexpected functions of chromatin remodelers in modulating the function of DNA recombinases and other accessory factors. Citation Format: Abdulaziz B. Hamid, Lauren E. Frank, Devi D. Nelakurti, Anna Valentine, Mehak Kaur, Ali Latif, Renee A. Bouley, Ruben C. Petreaca. Mutations in chromatin remodelers produce intra-chromosomal deletions in cancer cells [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: DNA Damage Repair: From Basic Science to Future Clinical Application; 2024 Jan 9-11; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2024;84(1 Suppl) nr B007.

Interplay between DNA damage repair and apoptosis shapes cancer evolution through aneuploidy and microsatellite instability

Aneuploidy as a driver of human cancer

Solving the chromosome puzzle of aneuploidy in cancer

Endogenous DNA Damage as a Source of Genomic Instability in Cancer

Evolving Insights: How DNA Repair Pathways Impact Cancer Evolution

and haploinsufficiency equip colonic epithelium for oncogenic transformation

A tug-of-war between driver and passenger mutations in cancer and other adaptive processes

Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure

Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy

Analysis of Mutations and Dysregulated Pathways Unravels Carcinogenic Effect and Clinical Actionability of Mutational Processes

Transient genomic instability drives tumorigenesis through accelerated clonal evolution

Genomic linkages dictate cancer evolution

The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution

Isogenic Cell Lines Derived from Specific Organ Metastases Exhibit Divergent Cytogenomic Aberrations

An aneuploidy epistasis map reveals metabolic vulnerabilities associated with supernumerary chromosomes in cancer

Abstract B007: Mutations in chromatin remodelers produce intra-chromosomal deletions in cancer cells

Fundamental immune-oncogenicity trade-offs define driver mutation fitness

The Importance of DNA Repair in Tumor Suppression

The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis

Abstract 4338: A pan-cancer single-cell analysis of intratumoral copy number diversity and evolution

Chromosomal instability and aneuploidy in cancer: from yeast to man